GMI-306

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameGMI-306

Drug Alias NameGMI-306

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionFibroblast growth factor receptors antagonists

TargetsFibroblast growth factor receptors

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGlycomed Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesGlycomed Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A